By Chris Lane
By Jeff Balke
By Aaron Reiss
By Angelica Leicht
By Dianna Wray
By Aaron Reiss
By Camilo Smith
By Craig Malisow
"Everybody here," explains Steve Stuyck, M.D. Anderson's vice president for public affairs, "abhors tobacco and is opposed to the marketing of tobacco products."
As Dr. Joel Dunnington has learned, however, that abhorrence is not so pronounced that it keeps scientists at M.D. Anderson from taking money from the Council for Tobacco Research, an arm of the tobacco industry that has been censured by no less an authority than the American Medical Association, an organization not exactly known for its cutting-edge activism.
Dunnington has been working -- unsuccessfully -- to wean M. D. Anderson, considered one of the nation's premier cancer research and treatment hospitals, from its reliance on tobacco-tainted funding. Last summer, the radiologist stood before his colleagues on M.D. Anderson's faculty senate and delivered an impassioned plea urging the cancer center not to accept research grants from the Council for Tobacco Research. His speech carried the day, as the faculty senators voted 15-12 in favor of his recommendation.
But Dunnington's eloquence was for naught. M.D. Anderson's research council, an internal group of faculty department heads who oversee research funding at the center, refused to go along with the faculty senate's vote. And without that group's backing, Dunnington's long-standing ambition to ban tobacco dollars was doomed, since it was assumed that LeMaistre, who helped write the landmark 1963 Surgeon General's report on the dangers of smoking, would change the institution's policy only if the research council supported the faculty senate vote.
"We did away with selling cigarettes at M.D. Anderson many years ago, as a statement that we are a cancer center and that we shouldn't be selling them," says an exasperated Dunnington. "But yet we'll still turn around and take the money from the profits on those sales to our patients and use [it] to do research."
Dunnington estimates that the Council for Tobacco Research -- which he dismisses as a "fraud" perpetrated by the tobacco industry -- has funded about $500,000 worth of research at M.D. Anderson in recent years. Dr. Anthony J. Mastromarino, M. D. Anderson's associate vice president for research, says the council provided only $176,000 in this fiscal year for three studies on mammary tumors, colon cancer and gene expression in muscle tissue. Those figures represent only a small fraction of the center's total research budget, which this year amounts to about $86 million. Both sides cite the relative monetary insignificance of the council's largess to bolster their arguments -- with opponents claiming it allows the tobacco industry to buy respectability for a pittance and proponents maintaining that it's such a small amount that it's hardly worth arguing about.
That the Council for Tobacco Research uses its research funding for its own public relations purposes is not contested by either side. The council was created in 1954 by the tobacco industry and to this day is funded by tobacco companies. From 1954 through 1991, the council's board of scientific advisors has bestowed funding of more than $185 million for 1,246 original articles by more than 850 scientists. That's a lot of money, but it pales when compared to the 1993 advertising budget of the tobacco industry -- about $5.2 billion.
In addition to its deployment in the public relations battle against anti-smoking forces, the council-funded research also is cited in defense of lawsuits against the tobacco industry, Dunnington says. In one recent unsuccessful lawsuit brought in Mississippi by the family of a deceased smoker, tobacco industry lawyers showed the jury a poster listing the institutions that received funding from the Council for Tobacco Research. M.D. Anderson was one of those listed.
"They had funded this much money, hundreds of millions of dollars over the past 30 years," Dunnington says the defense attorney told the jury. "And there was no clear-cut cause and effect of cigarettes and cancer and other diseases, but that they were a very interested and honorable industry and they were going to keep funding these things until they found something."
In reality, even those who support the acceptability of the funding admit -- even emphasize -- that very little of it supports the study of tobacco's effects on health. Mastromarino, after examining the grants M.D. Anderson has accepted from the council, acknowledges that "few if any dealt with any kind of pulmonary disease or tobacco-related illnesses, or how tobacco directly affects body systems or disease. It's really basic research."
One national survey showed 80 percent of the studies had nothing to do with tobacco. So at least in name, the Council for Tobacco Research is suspect. In one court case, U.S. District Court Judge H. Lee Sarokin branded the council a "hoax created for public relations purposes with no intention of seeking the truth or publishing it."
But scientific research funding isn't abundant these days, and Mastromarino admits that the scarcity is one reason M.D. Anderson has allowed its researchers to keep taking the money. "I'm not saying this necessarily justifies the position," he says, "but the money is going to be expended for research (anyway) and 'better my lab get it than Joe Blow's in another institution,' or someplace else, particularly during a time of tight budgets and shrinking research dollars."